All Gilead Sciences Inc news 9 hours ago New drug breakthrough can cure hep C in kids - WXIA-TV Atlanta ...children and adolescents is on the way, promising to help some of the silent victims of a nationwide heroin epidemic. A Cincinnati Children's Hospital Medical Center doctor who helped lead the research for the drug combination says the new......William BalistreriKayleeGilead SciencesInc.Cincinnati Children'sCincinnati Children's Pediatric Liver Care Center Yesterday Abusive specialty drug pricing threatens healthcare system - The Hill ...challenges facing American families and taxpayers than the high cost of healthcare. High health costs result in lower incomes, higher premiums and out-of-pocket costs, fewer jobs, higher taxes and deficits, and fewer available resources for......SovaldiGilead SciencesInc.SovaldiNational Coalition on Health CareAmerica 2 days ago Investors Shift to Healthcare, Retailers as Trump Rally Stalls - Newsmax ...the Parnassus Core Equity fund. As a result, Ahlsten said he has been adding to his positions in healthcare stocks such as Gilead Sciences Inc , Allergan PLC and Novartis AG. Healthcare stocks had fallen in price on concerns over possible drug...... 3 days ago After Trump rally, equity investors move into healthcare, retailers - Reuters ...the Parnassus Core Equity fund. As a result, Ahlsten said he has been adding to his positions in healthcare stocks such as Gilead Sciences Inc (GILD.O), Allergan PLC (AGN.N) and Novartis AG (NOVN.S). Healthcare stocks had fallen in price on...... 4 days ago MOLOGEN AG: New Strategic Orientation, Successful Capital Measures and Notable Study Progress in 2016 - Business Wire ...another immunotherapeutic agent started in the reporting period. As expected, the study advancements resulted in a slight increase in expenditure in the area of research and development. MOLOGEN secured the future funding – for both the company's......Executive Board of MOLOGEN AGAarhus University HospitalU.S.Matthias BaumannWalter Miller 7 days ago Biopharma facing stiffer opposition - Boston Globe Stock analysts already have lowered their profit estimates for drug makers such as Gilead Sciences Inc ., maker of a breakthrough, high-priced hepatitis C treatment, citing reduced profit potential. ■ Drug......WashingtonGeoffrey PorgesLeora SchiffMedicareHarry Glorikian 9 days ago Should The U.S. Government Buy A Drug Company To Save Money? - KERA North Texas Specifically buy Gilead Sciences Inc . Dr. Peter Bach, the director of health policy and outcomes at Memorial Sloan Kettering Cancer Center in......Gilead Sciences IncPeter BachDavid HigginbothamHarvoniU.S. 9 days ago Should The U.S. Government Buy A Drug Company To Save Money? - KPBS San Diego Specifically buy Gilead Sciences Inc . Dr. Peter Bach, the director of health policy and outcomes at Memorial Sloan Kettering Cancer Center in......Gilead Sciences IncPeter BachDavid HigginbothamHarvoniU.S. 12 days ago SynCardia Names New VP of Manufacturing and Facilities - Business Wire ...said Michael Garippa, President and CEO of SynCardia. “His track record of success in highly regulated industries, including medical devices, pharmaceuticals and aerospace, will help ensure that we continue to provide hospitals around the......SynCardia SystemsBrogieBF Goodrich AerospaceTUCSONBrian 20 days ago Gilead executive says pharmacy benefit managers keep prices high - Providence Business News NEW YORK - Gilead Sciences Inc .’s hepatitis C cure set off a firestorm of criticism over high drug prices in 2014 that hasn’t let up since. Now an executive says the company can’t cut the product’s price because middlemen who manage drug benefits...... 26 days ago Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 14 - Business Wire FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference in...... 27 days ago Trump visa crackdown threatens medical miracle search - Chicago Tribune ...biotech firms such as Amgen Inc. and Gilead Sciences Inc ., as well as overseas companies with stateside operations, rely on the world's best scientists and......U.S.Tech-Worker Visas Press TrumpDonald TrumpFacebook Inc.Google Inc.